Jing Li

机构：Hong Kong Baptist University, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin First Center Hospital, Peking Union Medical College Hospital, Sinovac Biotech, Vitenparken, Tianjin Medical University · ORCID：0000-0003-3684-3491

发表论文 68 篇 · 总被引 3311 次 · h-index 19

代表论文

• A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2 (2024 · Protein & Cell · 被引 41)
• 5S-Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner (2024 · Acta Pharmaceutica Sinica B · 被引 30)
• Managerial overconfidence and stock price crash risk (2024 · Finance research letters · 被引 19)
• A novel mRNA vaccine, TGGT1_278620 mRNA-LNP, prolongs the survival time in BALB/c mice with acute toxoplasmosis (2023 · Microbiology Spectrum · 被引 12)
• Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering (2025 · Proceedings of the National Academy of Sciences · 被引 11)
• Oxymatrine Alleviates Collagen-Induced Arthritis in Mice by Regulating the Immune Balance of T Cells (2023 · Molecules · 被引 10)